1. Home
  2. BANL vs SABS Comparison

BANL vs SABS Comparison

Compare BANL & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANL
  • SABS
  • Stock Information
  • Founded
  • BANL 2015
  • SABS 2014
  • Country
  • BANL Malaysia
  • SABS United States
  • Employees
  • BANL N/A
  • SABS N/A
  • Industry
  • BANL Oil Refining/Marketing
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BANL Energy
  • SABS Health Care
  • Exchange
  • BANL Nasdaq
  • SABS Nasdaq
  • Market Cap
  • BANL 25.3M
  • SABS 15.8M
  • IPO Year
  • BANL 2023
  • SABS N/A
  • Fundamental
  • Price
  • BANL $0.92
  • SABS $1.75
  • Analyst Decision
  • BANL
  • SABS Strong Buy
  • Analyst Count
  • BANL 0
  • SABS 5
  • Target Price
  • BANL N/A
  • SABS $11.80
  • AVG Volume (30 Days)
  • BANL 1.8M
  • SABS 13.9K
  • Earning Date
  • BANL 04-16-2025
  • SABS 08-07-2025
  • Dividend Yield
  • BANL N/A
  • SABS N/A
  • EPS Growth
  • BANL N/A
  • SABS N/A
  • EPS
  • BANL N/A
  • SABS N/A
  • Revenue
  • BANL $592,517,545.00
  • SABS $377,835.00
  • Revenue This Year
  • BANL N/A
  • SABS N/A
  • Revenue Next Year
  • BANL N/A
  • SABS N/A
  • P/E Ratio
  • BANL N/A
  • SABS N/A
  • Revenue Growth
  • BANL 35.93
  • SABS N/A
  • 52 Week Low
  • BANL $0.55
  • SABS $1.00
  • 52 Week High
  • BANL $1.35
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • BANL 52.94
  • SABS 47.74
  • Support Level
  • BANL $0.81
  • SABS $1.67
  • Resistance Level
  • BANL $1.03
  • SABS $1.87
  • Average True Range (ATR)
  • BANL 0.11
  • SABS 0.12
  • MACD
  • BANL 0.01
  • SABS -0.01
  • Stochastic Oscillator
  • BANL 64.66
  • SABS 51.72

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: